HIGHLIGHTS
SUMMARY
The treatment of choice even in intermediate- and lowrisk patients presenting with severe stenotic aortic valve disease. Especially patients presenting with the symptomatic pure severe aortic regurgitation benefit from the minimally invasive surgical methods, as in the most cases these patients are not eligible for transcatheter treatment. Since then, the implantation techniques of sutureless aortic valve prostheses have evolved and SU-AVR has proven to be a safe and effective treatment option in various indications and combined valve procedures. The authors sought to review the experience with SU-AVR in patients presenting with symptomatic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.